Colombo, 20 February 2024: In a groundbreaking move, Sunshine Healthcare Lanka Limited (SHL), the healthcare arm of Sunshine Holdings PLC, announces the introduction of Cavilon No Sting Barrier Film by 3M to the Sri Lankan market. As the exclusive distributor, SHL is set to revolutionize wound care by providing unparalleled access to high-quality skin protectant products, marking a significant milestone in the country’s healthcare landscape.
Acknowledging patient safety as a top priority, Sunshine Healthcare Lanka recognizes the crucial role of skin protection in preventing healthcare-associated skin damage. The skin, being the body’s largest organ, is vulnerable to various risks in healthcare settings, including prolonged exposure to moisture, friction, shear, adhesives, and irritants, leading to complex conditions such as Moisture Associated Skin Damage (MASD), Pressure Ulcer/Injury (PU/PI), and Medical Adhesive Related Skin Injury (MARSI).
In collaboration with 3M, a globally renowned healthcare innovator, Sunshine Healthcare Lanka is introducing Cavilon, a revolutionary skin protectant solution. The 3M Cavilon No Sting Barrier Film boasts a special terpolymer formula which provides exceptional flexibility and durability. This hypoallergenic and alcohol-free option ensures gentle and effective protection for at-risk skin without causing irritation.
Sayandhan, Chief Executive Officer of Sunshine Medical Devices and Lina Manufacturing, emphasized, “This is a significant milestone for Sunshine Healthcare Lanka Limited. It reflects our unwavering commitment to maintaining the highest standards of quality, efficiency, and customer satisfaction. Introducing 3M Cavilon No Sting Barrier Film to Sri Lanka reaffirms our dedication to delivering the best healthcare solutions and marks an essential step in our journey towards excellence. As we pioneer the distribution of 3M Cavilon No Sting Barrier Film, we are not just introducing a product; we are shaping the future of wound care in Sri Lanka, ensuring our community receives the best possible healthcare innovations.”
Cavilon offers comprehensive solutions for a spectrum of skin conditions, including pressure ulcers, friction- and shear-related injuries, medical adhesive-related skin damage (MARSI), periwound and peristomal skin damage, incontinence-associated dermatitis, and intertriginous dermatitis. With a head-to-toe approach, the unique formulation of Cavilon addresses the complex challenges of skin protection and has gained the trust of healthcare professionals worldwide.